ABEONA THERAPEUTICS INC. Restricted Cash and Cash Equivalents
ABEONA THERAPEUTICS INC. (ABEO) had Restricted Cash and Cash Equivalents of $338.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-13
- 2025-09-30: Restricted Cash and Cash Equivalents $338.00K.
- 2025-06-30: Restricted Cash and Cash Equivalents $338.00K.
- 2025-03-31: Restricted Cash and Cash Equivalents $338.00K.
- 2024-12-31: Restricted Cash and Cash Equivalents $338.00K.
| Period end | Restricted Cash and Cash Equivalents | Restricted Cash and Cash Equivalents as first filed |
|---|---|---|
| 2025-09-30 | $338.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $338.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $338.00K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $338.00K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $338.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $338.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $338.00K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $338.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $338.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $338.00K 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $338.00K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $338.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $5.34M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $5.89M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $5.89M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $5.89M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $975.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $975.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $975.00K 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $975.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $972.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $972.00K 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $1.11M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $1.11M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.11M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $1.11M 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $560.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $560.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $560.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $280.00K 10-Q · filed 2019-05-10 | |
| 2018-01-01 | $280.00K 10-K · filed 2019-03-18 | |
| 2017-12-31 | $280.00K 10-K · filed 2020-03-16 | $0.00 10-Q · filed 2018-05-10 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 | |
| 2012-12-31 | $0.00 10-K · filed 2013-03-20 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $330.00K 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $330.00K 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |